We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Generic Manufacturing Guidance on Polymorphic Ingredients
FDA Issues Generic Manufacturing Guidance on Polymorphic Ingredients
August 6, 2007
The FDA is recommending that generic manufacturers pay close attention to polymorphic forms of drug substances used in pharmaceutical processing operations, according to a new guidance issued last month.